Acro Biomedical Co (Acro Biomedical Co) Interest Expense : $-0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Acro Biomedical Co's interest expense for the three months ended in Jun. 2023 was $ -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Acro Biomedical Co's Operating Income for the three months ended in Jun. 2023 was $ -3.20 Mil. Acro Biomedical Co's Interest Expense for the three months ended in Jun. 2023 was $ -0.00 Mil. Acro Biomedical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Acro Biomedical Co Interest Expense Historical Data

The historical data trend for Acro Biomedical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Interest Expense Chart

Acro Biomedical Co Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

Acro Biomedical Co Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Acro Biomedical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Acro Biomedical Co (OTCPK:ACBM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Acro Biomedical Co's Interest Expense for the three months ended in Jun. 2023 was $-0.00 Mil. Its Operating Income for the three months ended in Jun. 2023 was $-3.20 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was $0.00 Mil.

Acro Biomedical Co's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Acro Biomedical Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Acro Biomedical Co (Acro Biomedical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038

Website

http://www.acrobiomedical.com

Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.

Executives

Pao-chi Chu

director, 10 percent owner, officer: CEO

2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines